Preimplantation Genetic Diagnosis Market's Future Lies in PGD for Aneuploidy Screening, Expected to Reach US$118.0 Mn by 2020
Preimplantation genetic diagnosis (PGD) is the genetic profiling of embryos before they are implanted and can also be of oocytes before fertilization. It is an adjuvant technique to in vitro fertilization (IVF), used for the detection of genetic conditions or diseases prior to the embryo being implanted. PGD is utilized for the screening of a wide range of medical abnormalities such as inheritable diseases, Down's syndrome, and traits of a number of other physiological abnormalities. In addition, the utilization of...
View full press release